Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Cryo Cell International (CCEL) Income from Continuing Operations: 2010-2025

Historic Income from Continuing Operations for Cryo Cell International (CCEL) over the last 16 years, with Q3 2025 value amounting to $749408.0.

  • Cryo Cell International's Income from Continuing Operations fell 2874.18% to $749408.0 in Q3 2025 from the same period last year, while for Aug 2025 it was -$788541.0, marking a year-over-year increase of 9116.61%. This contributed to the annual value of $87121.0 for FY2024, which is 10091.5% up from last year.
  • Cryo Cell International's Income from Continuing Operations amounted to $749408.0 in Q3 2025, which was down 2874.18% from $355785.0 recorded in Q2 2025.
  • Cryo Cell International's 5-year Income from Continuing Operations high stood at $1.2 million for Q2 2021, and its period low was -$11.2 million during Q4 2023.
  • Moreover, its 5-year median value for Income from Continuing Operations was $634719.0 (2022), whereas its average is -$380122.2.
  • Per our database at Business Quant, Cryo Cell International's Income from Continuing Operations crashed by 586362.04% in 2023 and then soared by 19676.98% in 2024.
  • Over the past 5 years, Cryo Cell International's Income from Continuing Operations (Quarter) stood at -$3.6 million in 2021, then skyrocketed by 94.85% to -$187638.0 in 2022, then plummeted by 5863.62% to -$11.2 million in 2023, then soared by 80.55% to -$2.2 million in 2024, then surged by 134.43% to $749408.0 in 2025.
  • Its Income from Continuing Operations was $749408.0 in Q3 2025, compared to $355785.0 in Q2 2025 and $282855.0 in Q1 2025.